Medication info
PioGlia Tablet (Pioglitazone Hydrochloride)

PioGlia Tablet (Pioglitazone Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Pioglitazone Hydrochloride›16.53mg / 1 tablet
Manufacturer / importer
Seongwon Adcock Pharm Co., Ltd.
Appearance
White to grayish-white round and convex tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 200703202 · Notified 2007.03.19 · Insurance code 664900660

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults · Children
Adult dose
This medicine is administered orally once daily, regardless of meals. For monotherapy, treatment may be initiated at 15 mg once daily. If an adequate effect is not achieved with the initial dose, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily with a sulfonylurea, metformin, or insulin. The maximum recommended dose should not exceed 30 mg once daily.
Child dose
Use is not recommended in children under 18 years of age because there is no experience with its use.

Ingredients

Manufacturer
Seongwon Adcock Pharm Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Blood sugar control disorder in patients with type 2 diabetes
View approved original text

This medication helps to improve blood sugar control in patients with type 2 diabetes as an adjunct to dietary therapy and exercise therapy. It can be used as monotherapy, and if there is no improvement in blood sugar despite using other oral hypoglycemic agents, it can be combined with sulfonylureas, metformin, or insulin. Nutritional counseling, weight loss, and exercise therapy are also very important for patients with type 2 diabetes, and these efforts greatly aid in maintaining the effectiveness of drug therapy as well as initial treatment. This medication assists in effective blood sugar management to improve the patient's health.

How to take

Adult dose

This medicine is administered orally once daily, regardless of meals. For monotherapy, treatment may be initiated at 15 mg once daily. If an adequate effect is not achieved with the initial dose, the dose may be increased to 30 mg once daily. For combination therapy, administer 15 mg once daily with a sulfonylurea, metformin, or insulin. The maximum recommended dose should not exceed 30 mg once daily.

Child dose

Use is not recommended in children under 18 years of age because there is no experience with its use.

Precautions

This medication is used to treat type 2 diabetes and works by lowering blood sugar with the help of insulin. However, in some patients, it may put stress on the heart leading to congestive heart failure or worsen pre-existing heart failure, so it is important to carefully observe symptoms such as weight changes, shortness of breath, and edema after starting treatment. Patients with heart failure or a history of heart failure should not use this medication, and it is not recommended for symptomatic heart failure patients. This medication may cause fluid retention, and it should be used cautiously in patients at risk for heart failure. If symptoms such as hematuria, urinary disturbances, or urgency occur during treatment, it is important to inform a doctor immediately due to the possibility of bladder cancer. Additionally, it should not be administered to those with hypersensitivity to this medication, liver disorders, severe renal impairment, diabetic ketoacidosis, type 1 diabetes, patients with active or a history of bladder cancer, or women who are pregnant or may become pregnant. Patients currently taking other oral hypoglycemic agents, premenopausal women, patients with edema or cardiovascular disease, those with renal dysfunction, patients with poor nutritional status, those engaging in vigorous exercise, patients with excessive alcohol intake, and the elderly should use this medication with caution. Side effects of this medication may include edema, headache, upper respiratory infection, myalgia, weight gain, hypoglycemia, back pain, dizziness, diarrhea, elevated serum creatine kinase (CK), hypertension, chest pain, fatigue, weakness, dyspepsia, nausea, itching, chest discomfort, tremors, chills, gastrointestinal disorders, epigastric discomfort, numbness, rigidity, discomfort in the head, liver enzyme increase, worsening of liver disease, eczema, arthralgia, knee abnormalities. If liver dysfunction is suspected, regular liver function tests are necessary, and if symptoms of hepatitis or significantly elevated serum liver enzyme levels occur, treatment should be stopped immediately. Premenopausal women may experience increased chances of pregnancy due to ovulation stimulation while taking this medication, so adequate contraceptive methods should be used. This medication should be used cautiously during pregnancy, and whether to administer it to nursing mothers should be decided carefully. In cases of overdose, no specific symptoms may appear, but appropriate treatment should be provided according to clinical symptoms. This medication is not recommended for use in children and patients under 18 years of age as safety and efficacy have not been established. For the elderly, dose adjustment is not necessary, but careful monitoring is required. Lastly, this medication should be stored out of reach of children and kept in its original container.

Side effects

Congestive heart failure, excessive and rapid weight changes, dyspnea, edema, fluid retention, inadequate blood sugar control, upper respiratory infection, headache, sinusitis, myalgia, pharyngitis, abdominal distension, weight gain, hypoglycemia, urinary tract infection, back pain, dizziness, diarrhea, elevated serum creatine kinase, hypertension, heart failure, limb pain, chest pain, death due to cardiovascular susceptibility, hospitalization due to exacerbation of congestive heart failure, emergency room visits due to congestive heart failure, liver failure, diabetic macular edema accompanied by vision reduction, elevated serum ALT levels, elevated serum bilirubin levels, decreased hemoglobin, decreased hematocrit, increased serum creatinine, dizziness, loss of appetite, constipation, upper abdominal pain, chest pain, fatigue, weakness, dyspepsia, nausea, dyspnea, itching, chest discomfort, tremor, chills, gastrointestinal disease, abdominal pain, epigastric discomfort, numbness, muscle rigidity, head discomfort, increased liver enzymes, worsening liver disease, urticaria, eczema, arthralgia, knee abnormalities, arm weakness, proteinuria, anxiety, insomnia, drowsiness, simple herpes, blurred vision, orthostatic hypotension, palpitations, stroke, sexual dysfunction, myocardial infarction, fracture

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container shielded from light and avoiding moist areas. The appropriate storage temperature is between 15 to 30 degrees Celsius, with approximately 25 degrees being the most suitable.

Appearance and packaging

Appearance

White to grayish-white round and convex tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.